English | Español

Technology/Innovation
+ Technology/Innovation
Amanda Rupp | May 1, 2016

Autism Speaks approves ban of aversive shock devices
+ Community
Amanda Rupp | May 1, 2016

AAFP brings advocacy issues to Capitol Hill
+ Community
Amanda Rupp | May 1, 2016

Advertisements shown to influence e-cigarette use among youth
+ Community
Amanda Rupp | May 1, 2016

Selection process begins for new research approach
+ Community
Amanda Rupp | May 1, 2016

Astellas appoints leaders in departments of Ethics and Compliance, U.S. Legal
+ Technology/Innovation
Amanda Rupp | May 1, 2016

FDA to evaluate oral fluconazole during pregnancy
+ Community
Amanda Rupp | May 1, 2016

ADA grants eight National Scientific and Health Care Achievement Awards
+ Technology/Innovation
Amanda Rupp | May 1, 2016

MSSNG program develops genome sequence for patients with autism

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation